306 related articles for article (PubMed ID: 7311430)
1. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
[No Abstract] [Full Text] [Related]
2. Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level.
Pados G; Kusztos D; Németh-Csóka M; Valyon M; Farkas K
Ther Hung; 1983; 31(2):59-61. PubMed ID: 6571183
[No Abstract] [Full Text] [Related]
3. Serum lipoprotein lipids after gemfibrozil treatment.
Schwandt P; Weisweiler P; Neureuther G
Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
[TBL] [Abstract][Full Text] [Related]
4. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
5. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
Machalke K; Djaja S; Richter E
Ther Ggw; 1982 May; 121(5):301-11. PubMed ID: 6953613
[No Abstract] [Full Text] [Related]
6. [Basic principles of drug therapy of hyperlipoproteinemia].
Romics L
Orv Hetil; 1988 Nov; 129(45):2391-9. PubMed ID: 3054710
[No Abstract] [Full Text] [Related]
7. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
8. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
Romics L; Karádi I; Simonyi E
Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
[No Abstract] [Full Text] [Related]
9. Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.
Sale JK; Johnstone JH
Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():71-5. PubMed ID: 7259072
[TBL] [Abstract][Full Text] [Related]
10. [Effect of antiatherosclerosis diet with different total caloric value on the level of high density lipoproteins cholesterol in patients with ischemic heart disease].
Samsonov MA; Frolova IA; Paramonova EG; Zubenko AD; Sirota II
Vopr Pitan; 1981; (5):15-20. PubMed ID: 7314609
[No Abstract] [Full Text] [Related]
11. [Clinical research on the hypolipidemic action of a probucol preparation].
Naumova R; Kerekovska M; Goranov I; Balabanski L
Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
[TBL] [Abstract][Full Text] [Related]
12. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Wechsler JG; Hutt V; Klör HU; Ditschuneit H
Artery; 1980; 8(6):519-29. PubMed ID: 7259531
[TBL] [Abstract][Full Text] [Related]
13. [Hyperlipoproteinemias, diet and drug therapy. Risk of arteriosclerosis and the lipoproteins].
Schwandt P
MMW Munch Med Wochenschr; 1980 Mar; 122(13):447-8. PubMed ID: 6769012
[No Abstract] [Full Text] [Related]
14. Effect of procetofen on apolipoprotein A I and B concentrations in hyperlipoproteinemia.
Viikari J; Solakivi-Jaakkola T; Lehtonen A
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):362-5. PubMed ID: 6811447
[TBL] [Abstract][Full Text] [Related]
15. [The when and how of therapy for hyperlipoproteinemia].
Mordasini R
Schweiz Med Wochenschr; 1978 Jan; 108(4):113-9. PubMed ID: 203028
[TBL] [Abstract][Full Text] [Related]
16. [The relation between lipoprotein fractions, sex and IHD in patients with primary hyperlipoproteinemia].
Hora C; Hanefeld M; Leonhardt W; Jacob F; Haller H
Z Gesamte Inn Med; 1982 Dec; 37(23):801-4. PubMed ID: 7164523
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
18. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension].
Dakovska L; Orbetzov M; Orbetzova V; Yarovska N
Paroi Arterielle; 1981; 7(1):15-22. PubMed ID: 7339537
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
[TBL] [Abstract][Full Text] [Related]
20. [Dietary treatment of hyperlipoproteinemia. Reduction of atherogenic lipid fractions in normal subjects].
Weisweiler P
Fortschr Med; 1985 Feb; 103(7):148-50. PubMed ID: 3972329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
